Neuropeptides
The efficacy of semax in the treatment of patients at different stages of ischemic stroke
Gusev EI, Martynov MY, Kostenko EV, et al. · Zh Nevrol Psikhiatr Im S S Korsakova · 2018
PMID: 29798983 · DOI: 10.17116/jnevro20181184261-68
Summary
Open clinical study evaluating intranasal semax across acute and recovery phases of ischemic stroke. Endpoints: NIHSS motor performance, Barthel index, plasma BDNF.
Citation hosted by NCBI. We link to the source so the researcher can read the abstract, full text, or references-cited list directly.
Compounds referenced in this study
- View product →SemaxSynthetic ACTH (4-7) analog studied in neuroprotection and BDNF-pathway research.
Guides covering this compound
More Neuropeptides citations
- Efficacy and Safety of Cerebrolysin for Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled TrialsNeurol Sci · 2018
- Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trialStroke · 2012
- Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurastheniaZh Nevrol Psikhiatr Im S S Korsakova · 2007